课题基金 / 基金详情

THERAPEUTIC EFFECTS AND ABUSE OF GABA(A) MODULATORS

THERAPEUTIC EFFECTS AND ABUSE OF GABA(A) MODULATORS
GABA(A) 调节剂的治疗效果和滥用
批准号:
8357917
负责人:
JAMES K ROWLETT
金额:
$1.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30

项目摘要

项目成果

JAMES K ROWLETT的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是利用资源的许多研究子项目之一。 由NIH/NCRR资助的中心拨款提供。对子项目的主要支持 子项目的首席调查员可能是由其他来源提供的, 包括美国国立卫生研究院的其他来源。为子项目列出的总成本可能 表示该子项目使用的中心基础设施的估计数量, 不是由NCRR赠款提供给次级项目或次级项目工作人员的直接资金。 苯二氮类药物(BZS)被广泛用作抗焦虑药、催眠药、肌肉松弛药和抗惊厥药。尽管BZS被认为是现代医学中最安全的处方药之一,但它们的用途受到许多副作用的限制,包括不想要的镇静、运动能力受损和上瘾的可能性。该项目旨在确定BZ类药物临床有益与不良副作用背后的GABA(A)受体亚型机制。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Benzodiazepines (BZs) are prescribed widely as anxiolytics, hypnotics, muscle relaxants, and anticonvulsants. Although BZs are considered to be among the safest prescription drugs in modern medicine, their utility is constrained by a number of side effects, including unwanted sedation, impaired motor performance, and the liability for addiction. This project seeks to identify the GABA(A) receptor subtype mechanisms underlying the clinically beneficial vs. unwanted side effects of BZ-type drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment
  • 批准号:
    10162574
  • 项目类别:
  • 资助金额:
    $40.27万
  • 财政年份:
    2017
  • 负责人:
    JAMES K ROWLETT
  • 依托单位:
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation
  • 批准号:
    8322247
  • 项目类别:
  • 资助金额:
    $60.22万
  • 财政年份:
    2012
  • 负责人:
    JAMES K ROWLETT
  • 依托单位:
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation
海外基金